報告摘要

The global Cancer Drug based on CAR-T market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the Cancer Drug based on CAR-T market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cancer Drug based on CAR-T market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cancer Drug based on CAR-T market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cancer Drug based on CAR-T include Bristol-Myers Squibb, Fosun Kite Biotechnology, Gilead Sciences and Novartis, among others; in 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global Cancer Drug based on CAR-T market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cancer Drug based on CAR-T. Key Companies & Market Share Insights This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking. Cancer Drug based on CAR-T Market by Company Bristol-Myers Squibb Fosun Kite Biotechnology Gilead Sciences Novartis Cancer Drug based on CAR-T Segment by Type Allogeneic Autologous Cancer Drug based on CAR-T Segment by Application Hospital Pharmacy Other Cancer Drug based on CAR-T Segment by Region North America United States Canada Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Drug based on CAR-T market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of Cancer Drug based on CAR-T and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Drug based on CAR-T. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Cancer Drug based on CAR-T companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Cancer Drug based on CAR-T by Type 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) 2.2.2 Allogeneic 2.2.3 Autologous 2.3 Cancer Drug based on CAR-T by Application 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.3.2 Hospital 2.3.3 Pharmacy 2.3.4 Other 2.4 Assumptions and Limitations 3 Cancer Drug based on CAR-T Breakdown Data by Type 3.1 Global Cancer Drug based on CAR-T Historic Market Size by Type (2021-2026) 3.2 Global Cancer Drug based on CAR-T Forecasted Market Size by Type (2027-2032) 4 Cancer Drug based on CAR-T Breakdown Data by Application 4.1 Global Cancer Drug based on CAR-T Historic Market Size by Application (2021-2026) 4.2 Global Cancer Drug based on CAR-T Forecasted Market Size by Application (2027-2032) 5 Global Growth Trends 5.1 Global Cancer Drug based on CAR-T Market Perspective (2021-2032) 5.2 Global Cancer Drug based on CAR-T Growth Trends by Region 5.2.1 Global Cancer Drug based on CAR-T Market Size by Region: 2021 VS 2025 VS 2032 5.2.2 Cancer Drug based on CAR-T Historic Market Size by Region (2021-2026) 5.2.3 Cancer Drug based on CAR-T Forecasted Market Size by Region (2027-2032) 5.3 Cancer Drug based on CAR-T Market Dynamics 5.3.1 Cancer Drug based on CAR-T Industry Trends 5.3.2 Cancer Drug based on CAR-T Market Drivers 5.3.3 Cancer Drug based on CAR-T Market Challenges 5.3.4 Cancer Drug based on CAR-T Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Cancer Drug based on CAR-T Players by Revenue 6.1.1 Global Top Cancer Drug based on CAR-T Players by Revenue (2021-2026) 6.1.2 Global Cancer Drug based on CAR-T Revenue Market Share by Players (2021-2026) 6.2 Global Cancer Drug based on CAR-T Industry Players Ranking, 2023 VS 2024 VS 2025 6.3 Global Key Players of Cancer Drug based on CAR-T Head Office and Area Served 6.4 Global Cancer Drug based on CAR-T Players, Product Type & Application 6.5 Global Cancer Drug based on CAR-T Manufacturers Established Date 6.6 Global Cancer Drug based on CAR-T Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Cancer Drug based on CAR-T Market Size (2021-2032) 7.2 North America Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 7.3 North America Cancer Drug based on CAR-T Market Size by Country (2021-2026) 7.4 North America Cancer Drug based on CAR-T Market Size by Country (2027-2032) 7.5 United States 7.5 United States 7.6 Canada 7.7 Mexico 8 Europe 8.1 Europe Cancer Drug based on CAR-T Market Size (2021-2032) 8.2 Europe Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 8.3 Europe Cancer Drug based on CAR-T Market Size by Country (2021-2026) 8.4 Europe Cancer Drug based on CAR-T Market Size by Country (2027-2032) 8.5 Germany 8.6 France 8.7 U.K. 8.8 Italy 8.9 Spain 8.10 Russia 8.11 Netherlands 8.12 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Cancer Drug based on CAR-T Market Size (2021-2032) 9.2 Asia-Pacific Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 9.3 Asia-Pacific Cancer Drug based on CAR-T Market Size by Country (2021-2026) 9.4 Asia-Pacific Cancer Drug based on CAR-T Market Size by Country (2027-2032) 9.5 China 9.6 Japan 9.7 South Korea 9.8 India 9.9 Australia 9.10 China Taiwan 9.11 Southeast Asia 10 South America 10.1 South America Cancer Drug based on CAR-T Market Size (2021-2032) 10.2 South America Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 10.3 South America Cancer Drug based on CAR-T Market Size by Country (2021-2026) 10.4 South America Cancer Drug based on CAR-T Market Size by Country (2027-2032) 10.5 Brazil 10.6 Argentina 10.7 Chile 10.8 Colombia 10.9 Peru 11 Middle East & Africa 11.1 Middle East & Africa Cancer Drug based on CAR-T Market Size (2021-2032) 11.2 Middle East & Africa Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 11.3 Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2021-2026) 11.4 Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2027-2032) 11.5 Saudi Arabia 11.6 Israel 11.7 United Arab Emirates 11.8 Turkey 11.9 Iran 11.10 Egypt 12 Players Profiled 12.1 Bristol-Myers Squibb 12.1.1 Bristol-Myers Squibb Company Information 12.1.2 Bristol-Myers Squibb Business Overview 12.1.3 Bristol-Myers Squibb Revenue in Cancer Drug based on CAR-T Business (2021-2026) 12.1.4 Bristol-Myers Squibb Cancer Drug based on CAR-T Product Portfolio 12.1.5 Bristol-Myers Squibb Recent Developments 12.2 Fosun Kite Biotechnology 12.2.1 Fosun Kite Biotechnology Company Information 12.2.2 Fosun Kite Biotechnology Business Overview 12.2.3 Fosun Kite Biotechnology Revenue in Cancer Drug based on CAR-T Business (2021-2026) 12.2.4 Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Portfolio 12.2.5 Fosun Kite Biotechnology Recent Developments 12.3 Gilead Sciences 12.3.1 Gilead Sciences Company Information 12.3.2 Gilead Sciences Business Overview 12.3.3 Gilead Sciences Revenue in Cancer Drug based on CAR-T Business (2021-2026) 12.3.4 Gilead Sciences Cancer Drug based on CAR-T Product Portfolio 12.3.5 Gilead Sciences Recent Developments 12.4 Novartis 12.4.1 Novartis Company Information 12.4.2 Novartis Business Overview 12.4.3 Novartis Revenue in Cancer Drug based on CAR-T Business (2021-2026) 12.4.4 Novartis Cancer Drug based on CAR-T Product Portfolio 12.4.5 Novartis Recent Developments 13 Report Conclusion 14 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cancer Drug based on CAR-T Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Cancer Drug based on CAR-T Revenue Market Share by Type (2021-2026) Table 7. Global Cancer Drug based on CAR-T Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Cancer Drug based on CAR-T Revenue Market Share by Type (2027-2032) Table 9. Global Cancer Drug based on CAR-T Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Cancer Drug based on CAR-T Revenue Market Share by Application (2021-2026) Table 11. Global Cancer Drug based on CAR-T Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Cancer Drug based on CAR-T Revenue Market Share by Application (2027-2032) Table 13. Global Cancer Drug based on CAR-T Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cancer Drug based on CAR-T Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cancer Drug based on CAR-T Market Share by Region (2021-2026) Table 16. Global Cancer Drug based on CAR-T Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cancer Drug based on CAR-T Market Share by Region (2027-2032) Table 18. Cancer Drug based on CAR-T Industry Trends Table 19. Cancer Drug based on CAR-T Industry Drivers Table 20. Cancer Drug based on CAR-T Industry Opportunities and Challenges Table 21. Cancer Drug based on CAR-T Market Restraints Table 22. Global Top Cancer Drug based on CAR-T Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Cancer Drug based on CAR-T Revenue Market Share by Players (2021-2026) Table 24. Global Cancer Drug based on CAR-T Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Cancer Drug based on CAR-T, Headquarters and Area Served Table 26. Global Cancer Drug based on CAR-T Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Cancer Drug based on CAR-T by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Cancer Drug based on CAR-T Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Cancer Drug based on CAR-T Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Cancer Drug based on CAR-T Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Cancer Drug based on CAR-T Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Cancer Drug based on CAR-T Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Cancer Drug based on CAR-T Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Cancer Drug based on CAR-T Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Cancer Drug based on CAR-T Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Cancer Drug based on CAR-T Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2027-2032) & (US$ Million) Table 45. Bristol-Myers Squibb Company Information Table 46. Bristol-Myers Squibb Business Overview Table 47. Bristol-Myers Squibb Revenue in Cancer Drug based on CAR-T Business (2021-2026) & (US$ Million) Table 48. Bristol-Myers Squibb Cancer Drug based on CAR-T Product Portfolio Table 49. Bristol-Myers Squibb Recent Developments Table 50. Fosun Kite Biotechnology Company Information Table 51. Fosun Kite Biotechnology Business Overview Table 52. Fosun Kite Biotechnology Revenue in Cancer Drug based on CAR-T Business (2021-2026) & (US$ Million) Table 53. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Portfolio Table 54. Fosun Kite Biotechnology Recent Developments Table 55. Gilead Sciences Company Information Table 56. Gilead Sciences Business Overview Table 57. Gilead Sciences Revenue in Cancer Drug based on CAR-T Business (2021-2026) & (US$ Million) Table 58. Gilead Sciences Cancer Drug based on CAR-T Product Portfolio Table 59. Gilead Sciences Recent Developments Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Revenue in Cancer Drug based on CAR-T Business (2021-2026) & (US$ Million) Table 63. Novartis Cancer Drug based on CAR-T Product Portfolio Table 64. Novartis Recent Developments Table 65. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cancer Drug based on CAR-T Product Image Figure 5. Global Cancer Drug based on CAR-T Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Cancer Drug based on CAR-T Market Share by Type: 2025 VS 2032 Figure 7. Allogeneic Product Figure 8. Autologous Product Figure 9. Global Cancer Drug based on CAR-T Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cancer Drug based on CAR-T Market Share by Application: 2025 VS 2032 Figure 11. Hospital Product Figure 12. Pharmacy Product Figure 13. Other Product Figure 14. Global Cancer Drug based on CAR-T Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Cancer Drug based on CAR-T Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Cancer Drug based on CAR-T Market Share by Region: 2025 VS 2032 Figure 17. Global Cancer Drug based on CAR-T Market Share by Players in 2025 Figure 18. Global Cancer Drug based on CAR-T Manufacturers Established Date Figure 19. Global Top 5 and 10 Cancer Drug based on CAR-T Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 23. United States Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 26. Europe Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 28. Germany Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 38. China Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 43. Australia Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 48. Brazil Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Cancer Drug based on CAR-T Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Cancer Drug based on CAR-T Business (2021-2026) Figure 54. Fosun Kite Biotechnology Revenue Growth Rate in Cancer Drug based on CAR-T Business (2021-2026) Figure 55. Gilead Sciences Revenue Growth Rate in Cancer Drug based on CAR-T Business (2021-2026) Figure 56. Novartis Revenue Growth Rate in Cancer Drug based on CAR-T Business (2021-2026)

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

Cancer Drug based on CAR-T Industry Research Report 2026

授權報價

報告摘要

提及公司